Penicillin-binding protein 7/8 contributes to the survival of Acinetobacter baumannii in vitro and in vivo

Journal of Infectious Diseases

Volumn 199, Issue 4, 2009, Pages 513-521

  Russo, Thomas A ^a,b,d   MacDonald, Ulrike ^a,b   Beanan, Janet M ^a,b   Olson, Ruth ^a,b   MacDonald, Ian J ^a,b   Sauberan, Shauna L ^a,b   Luke, Nicole R ^a,b   Schultz, L Wayne ^a,b,c   Umland, Timothy C ^a,b,c  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c HAUPTMAN WOODWARD MEDICAL RESEARCH INSTITUTE   (United States)

^d Division of Infectious Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG BINDING PROTEIN; PENICILLIN BINDING PROTEIN 7; PENICILLIN BINDING PROTEIN 8; PEPTIDOGLYCAN; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; CONTROL GROUP; CONTROLLED STUDY; ELECTRON MICROSCOPY; HOST RESISTANCE; IN VITRO STUDY; IN VIVO STUDY; MUTANT; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; RAT; SCREENING; STATISTICAL SIGNIFICANCE; TRANSPOSON;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; AMINO ACID SEQUENCE; ANIMALS; BLOOD BACTERICIDAL ACTIVITY; COMPLEMENT SYSTEM PROTEINS; COMPUTER SIMULATION; DATA INTERPRETATION, STATISTICAL; DISEASE MODELS, ANIMAL; DNA TRANSPOSABLE ELEMENTS; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; MOLECULAR SEQUENCE DATA; MUTATION; PENICILLIN-BINDING PROTEINS; PNEUMONIA, BACTERIAL; RATS; SOFT TISSUE INFECTIONS; URINE;

EID: 61849153413     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/596317     Document Type: Article

References (50)

1. Munoz-Price LS, Weinstein RA. Acinetobacter infection. N Engl J Med 2008; 358:1271-81.
2. Fournier PE, Richet H. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis 2006; 42:692-9.
3. Richet H, Fournier PE. Nosocomial infections caused by Acinetobacter baumannii: a major threat worldwide. Infect Control Hosp Epidemiol 2006; 27:645-6.
4. Joly-Guillou ML. Clinical impact and pathogenicity of Acinetobacter. Clin Microbiol Infect 2005; 11:868-73.
5. Falagas ME, Karveli EA. The changing global epidemiology of Acinetobacter baumannii infections: a development with major public health implications. Clin Microbiol Infect 2007; 13:117-9.
6. Gaynes R, Edwards JR. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 2005; 41:848-54.
7. Anstey NM, Currie BJ, Hassell M, Palmer D, Dwyer B, Seifert H. Community-acquired bacteremic Acinetobacter pneumonia in tropical Australia is caused by diverse strains of Acinetobacter baumannii, with carriage in the throat in at-risk groups. J Clin Microbiol 2002; 40:685-6.
8. Chen MZ, Hsueh PR, Lee LN, Yu CJ, Yang PC, Luh KT. Severe community-acquired pneumonia due to Acinetobacter baumannii. Chest 2001; 120:1072-7.
9. Tong MJ. Septic complications of war wounds. JAMA 1972; 219:1044-7.
10. Centers for Disease Control and Prevention. Acinetobacter baumannii infections among patients at military medical facilities treating injured US service members, 2002-2004. MMWR 2004; 53:1063-6.
11. Scott P, Deye G, Srinivasan A, et al. An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq. Clin Infect Dis 2007; 44:1577-84.
12. Davis KA, Moran KA, McAllister CK, Gray PJ. Multidrug-resistant Acinetobacter extremity infections in soldiers. Emerg Infect Dis 2005; 11:1218-24.
13. Maegele M, Gregor S, Steinhausen E, et al. The long-distance tertiary air transfer and care of tsunami victims: injury pattern and microbiological and psychological aspects. Crit Care Med 2005; 33:1136-40.
14. Rice LB. Challenges in identifying new antimicrobial agents effective for treating infections with Acinetobacter baumannii and Pseudomonas aeruginosa. Clin Infect Dis 2006; 43(Suppl):S100-5.
15. Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 2007; 51:3471-84.
16. Sunenshine RH, Wright MO, Maragakis LL, et al. Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg Infect Dis 2007; 13:97-103.
17. Paterson DL, Doi Y. A step closer to extreme drug resistance (XDR) in gram-negative bacilli. Clin Infect Dis 2007; 45:1179-81.
18. Talbot GH, Bradley J, Edwards JE Jr, Gilbert D, Scheld M, Bartlett JG. Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin Infect Dis 2006; 42:657-68.
19. Loehfelm TW, Luke NR, Campagnari AA. Identification and characterization of an Acinetobacter baumannii biofilm-associated protein. J Bacteriol 2008; 190:1036-44.
20. Romeis T, Holtje JV. Penicillin-binding protein 7/8 of Escherichia coli is a DD-endopeptidase. Eur J Biochem 1994; 224:597-604.
21. Denome SA, Elf PK, Henderson TA, Nelson DE, Young KD. Escherichia coli mutants lacking all possible combinations of eight penicillin binding proteins: viability, characteristics, and implications for peptidoglycan synthesis. J Bacteriol 1999; 181:3981-93.
22. Meberg BM, Paulson AL, Priyadarshini R, Young KD. Endopeptidase penicillin-binding proteins 4 and 7 play auxiliary roles in determining uniform morphology of Escherichia coli. J Bacteriol 2004; 186:8326-36.
23. Henderson TA, Dombrosky PM, Young KD. Artifactual processing of penicillin-binding proteins 7 and 1b by the OmpT protease of Escherichia coli. J Bacteriol 1994; 176:256-9.
24. Romeis T, Holtje JV. Specific interaction of penicillin-binding proteins 3 and 7/8 with soluble lytic transglycosylase in Escherichia coli. J Biol Chem 1994; 269:21603-7.
25. Priyadarshini R, de Pedro MA, Young KD. Role of peptidoglycan amidases in the development and morphology of the division septum in Escherichia coli. J Bacteriol 2007; 189:5334-47.
26. Priyadarshini R, Popham DL, Young KD. Daughter cell separation by penicillin-binding proteins and peptidoglycan amidases in Escherichia coli. J Bacteriol 2006; 188:5345-55.
27. Sauvage E, Kerff F, Terrak M, Ayala JA, Charlier P. The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis. FEMS Microbiol Rev 2008; 32:234-58.
28. Ecker JA, Massire C, Hall TA, et al. Identification of Acinetobacter species and genotyping of Acinetobacter baumannii by multilocus PCR and mass spectrometry. J Clin Microbiol 2006; 44:2921-32.
29. Arnold K, Bordoli L, Kopp J, Schwede T. The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 2006; 22:195-201.
30. Guex N, Peitsch MC. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 1997; 18:2714-23.
31. Schwede T, Kopp J, Guex N, Peitsch MC. SWISS-MODEL: an automated protein homology-modeling server. Nucleic Acids Res 2003; 31:3381-5.
32. Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 2004; 60:2126-32.
33. Larkin MA, Blackshields G, Brown NP, et al. Clustal W and Clustal X version 2.0. Bioinformatics 2007; 23:2947-8.
34. Krissinel E, Henrick K. Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions. Acta Crystallogr D Biol Crystallogr 2004; 60:2256-68.
35. Russo TA, Beanan JM, Olson R, et al. Rat pneumonia and soft-tissue infection models for the study of Acinetobacter baumannii biology. Infect Immun 2008; 76:3577-86.
36. Russo TA, Bartholomew LA, Davidson BA, et al. Total extracellular surfactant is increased but abnormal in a rat model of gram-negative bacterial pneumonia. Am J Physiol Lung Cell Molec Physiol 2002; 283:L655-63.
37. Russo TA, Davidson BA, Carlino-MacDonald UB, Helinski JD, Priore RL, Knight PR 3rd. The effects of Escherichia coli capsule, O-antigen, host neutrophils, and complement in a rat model of gram-negative pneumonia. FEMS Microbiol Lett 2003; 226:355-61.
38. Russo T, Sharma G, Brown C, Campagnari A. The loss of the O4 antigen moiety from the lipopolysaccharide of an extraintestinal isolate of Escherichia coli has only minor effects on serum sensitivity and virulence in vivo. Infect Immun 1995; 63:1263-9.
39. Nazareth H, Genagon SA, Russo TA. Extraintestinal pathogenic Escherichia coli survives within neutrophils. Infect Immun 2007; 75:2776-85.
40. Russo TA, Jodush ST, Brown JJ, Johnson JR. Identification of two previously unrecognized genes (guaA, argC) important for uropathogenesis. Mol Microbiol 1996; 22:217-29.
41. Russo T, Carlino U, Mong A, Jodush S. Identification of genes in an extraintestinal isolate of Escherichia coli with increased expression after exposure to human urine. Infect Immun 1999; 67:5306-14.
42. Nicholas RA, Krings S, Tomberg J, Nicola G, Davies C. Crystal structure of wild-type penicillin-binding protein 5 from Escherichia coli: implications for deacylation of the acyl-enzyme complex. J Biol Chem 2003;278:52826-33.
43. Morlot C, Pernot L, Le Gouellec A, et al. Crystal structure of a peptidoglycan synthesis regulatory factor (PBP3) from Streptococcus pneumoniae. J Biol Chem 2005; 280:15984-91.
44. Fonze E, Vermeire M, Nguyen-Disteche M, Brasseur R, Charlier P. The crystal structure of a penicilloyl-serine transferase of intermediate penicillin sensitivity: the DD-transpeptidase of streptomyces K15. J Biol Chem 1999; 274:21853-60.
45. Acquatella H, Little PJ, de Wardener HE, Coleman JC. The effect of urine osmolality and pH on the bactericidal activity of plasma. Clin Sci 1967; 33:471-80.
46. Beeson PB, Rowley D. The anticomplementary effect of kidney tissue; its association with ammonia production. J Exp Med 1959; 110:685-97.
47. Macheboeuf P, Contreras-Martel C, Job V, Dideberg O, Dessen A. Penicillin binding proteins: key players in bacterial cell cycle and drug resistance processes. FEMS Microbiol Rev 2006; 30:673-91.
48. Stewart GC. Taking shape: control of bacterial cell wall biosynthesis. Mol Microbiol 2005; 57:1177-81.
49. Vollmer W, Joris B, Charlier P, Foster S. Bacterial peptidoglycan (murein) hydrolases. FEMS Microbiol Rev 2008; 32:259-86.
50. S- dependent carbonstarvation induction of pbpG (PBP 7) is required for the starvation-stress response in Salmonella enterica serovar Typhimurium. Microbiology 2007; 153:2148-58.